article · PubMed
Background and Objective: Left ventricular hypertrophy (LVH) is an increase in left ventricular mass due to an increase in cardiomyocyte size. It is said to be a strong predictor of cardiovascular diseases. Detection of LVH is important as early diagnosis and initiation of measures can reduce/halt progression or even cause regression, resulting in prevention or delay of unfavourable cardiovascular outcomes. There is limited data on the frequency of electrocardiographic LVH in hospital population (in-patient and out-patient) in Nigeria. Therefore, the study aimed to estimate the frequency of ECG-diagnosed LVH in hospital patients in Ibadan. Method: The study was conducted at the cardiology unit of UCH, Ibadan. 12-Lead ECGs done between 01/01/2023 to 30/06/2023 for adult men and women 18 years and above were studied. Diagnosis of LVH was based on either Sokolow- Lyon or Cornell voltage criteria. Results: A total of 1678 tracings were analyzed (male - 701, female - 977). LVH was present in 399 tracings (23.8%, 238 cases per thousand), and was significantly more frequent in males than females (28.8% vs. 20.16%). Frequency increased with increasing age. LVH was noted to be significantly associated with incident atrial fibrillation (AF), other arrhythmias, and left atrial enlargement with odds ratios of 3.29 (95% CI: 1.60-6.80), 1.74 (95% CI: 1.17-2.58) and 3.35 (95% CI: 2.52-4.46) respectively. Conclusion: The frequency of ECG-detected LVH was 23.8% in UCH. It was predominantly seen in males and significantly associated with AF, other arrhythmias and left atrial enlargement.
This page summarises published work. The authoritative version sits with the publisher.
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.